Studies have shown that LOX secreted from hypoxic primary tumor cells accumulates in the pre-metastatic sites; LOX is an indispensable factor for recruiting bone marrow-derived CD11b+ cells (i.e., immature myeloid progenitor cells) to metastatic sites [19, 20]. The gene discussed is LOX; the disease is neoplasm.